ARS Pharmaceuticals, Inc. (SPRY) Gross profit
ARS Pharmaceuticals, Inc. (SPRY) annual gross profit history from SEC filings — each fiscal year as reported.
$89.1MFY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $89.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice